Jacob Teixeira

Spearheaded enterprise strategy and transformation initiatives for CASL, advising CEO and CFO on portfolio optimization and resource allocation.

Co-led a $30M restructuring initiative relocating operations from US to UK, delivering executive-level business cases with financial modeling and risk analysis.

• Achieved $27.9M in verified savings through supplier portfolio optimization and contract restructuring, enabling reinvestment in strategic initiatives.
• Reduced budget variance by 36% using advanced forecasting and scenario planning; developed proprietary decision tools for multi-million-dollar investments.
• Directed cross-border strategic planning for international expansion, addressing regulatory, sourcing, and operational risks.
• Established a global PBMC Clinical Site Network (15+ sites), realizing 22% cost reduction while enhancing flexibility and risk diversification.
• Implemented an enterprise project management system rollout, improving portfolio visibility and reducing cycle time by 18%.
• Created mentorship and capability-building programs that cut new-hire ramp time by 40%.

Directed business operations and strategic planning across three divisions, with $20M+ P&L responsibility.

Led cross-functional team of 12, aligning operational capabilities with corporate growth strategies.

• Optimized processes for BioStorage turnaround, reducing backlog by 75% and boosting client satisfaction by 35%.
• Co-developed go-to-market strategies for new services, contributing $15M in revenue growth.
• Managed over 30 strategic accounts, achieving 98% client retention through partnership-focused engagement.
• Built and scaled a global biospecimen supplier network, ensuring compliance and cost competitiveness.
• Conducted operational due diligence for biobank partnerships, assessing financial viability and scalability.
• Expanded market positioning through executive-approved business case initiatives.

• Renegotiated contracts, saving over $500K; led onboarding and contracting of more than 20 biomarker sites, expanding sourcing capabilities, reducing supply chain risk, and improving strategic flexibility for business growth.
• Redesigned the procurement workflow with a 30% cycle time reduction, presenting a business case to leadership, resulting in standardized protocols adopted enterprise-wide.

• Managed 20+ EHR accounts; led software customization and implementation at 25+ HCA sites.
• Improved deployment documentation and blood bank workflows for new lab systems.
• Provided market insights influencing product development roadmap and feature prioritization decisions, contributing to strategic product evolution.
• Partnered with healthcare executives to align technology implementations with institutional strategic objectives, maintaining 100% client satisfaction and driving strategic partnership renewals